Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mary Eileen Dolan (M Eileen Dolan)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer medicine

The pharmacogenomics journal

Cancer

University of Chicago

Purdue University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chicago

United States

Associate Director of Education, University of Chicago Comprehensive Cancer Center

Education History

Purdue University Jul 30o 1979 - Sep 20o 1983

United States

PHD :: Medicinal Chemistry

Publications

Victoria A Sanchez, Megan M Shuey, Paul C Dinh, Patrick O Monahan, Sophie D Fosså, Howard D Sesso, Mary Eileen Dolan, Lawrence H Einhorn, David J Vaughn, Neil E Martin, Darren R Feldman, Kurt Kroenke, Chunkit Fung, Robert D Frisina, Lois B Travis
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Victoria A Sanchez, Megan M Shuey, Paul C Dinh, Patrick O Monahan, Sophie D Fosså, Howard D Sesso, Mary Eileen Dolan, Lawrence H Einhorn, David J Vaughn, Neil E Martin, Darren R Feldman, Kurt Kroenke, Chunkit Fung, Robert D Frisina, Lois B Travis
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mohammad Shahbazi, Xindi Zhang, Paul C Dinh, Victoria A Sanchez, Matthew R Trendowski, Megan M Shuey, Tessa Nguyen, null null, Darren R Feldman, David J Vaughn, Chunkit Fung, Christian Kollmannsberger, Neil E Martin, Lawrence H Einhorn, Nancy J Cox, Robert D Frisina, Lois B Travis, Mary Eileen Dolan
Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer. Cancer medicine (2022)
Xindi Zhang, Matthew R Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C Dinh, Megan M Shuey, null null, Darren R Feldman, Robert J Hamilton, David J Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E Martin, Victoria A Sanchez, Robert D Frisina, Lawrence H Einhorn, Nancy J Cox, Lois B Travis, Mary Eileen Dolan
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy. Cancer medicine 11 (14) (2022)
Megan A Mekinda, Michelle L Domecki, Kathleen H Goss, Mary Eileen Dolan
Adapting Pathway Programs to the Virtual World: Insights from the Chicago EYES on Cancer Response to COVID-19-Related Disruptions to Training. Journal of STEM outreach 4 (3) (2021)
Matthew R Trendowski, Jessica L Baedke, Yadav Sapkota, Lois B Travis, Xindi Zhang, Omar El Charif, Heather E Wheeler, Wendy M Leisenring, Leslie L Robison, Melissa M Hudson, Lindsay M Morton, Kevin C Oeffinger, Rebecca M Howell, Gregory T Armstrong, Smita Bhatia, Mary Eileen Dolan
Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer 127 (21) (2021)
Eric R Gamazon, Matthew R Trendowski, Yujia Wen, Claudia Wing, Shannon M Delaney, Won Huh, Shan Wong, Nancy J Cox, Mary Eileen Dolan
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Scientific reports 8 (1) (2018)
Ruowang Li, Dokyoon Kim, Heather E Wheeler, Scott M Dudek, Mary Eileen Dolan, Marylyn DeRiggi Ritchie
Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity. The pharmacogenomics journal 19 (2) (2018)

Mary Eileen Dolan.css-eqlu8i{font-size:small;padding-left:4px;} (M Eileen Dolan)

Publication Activity (10 Years)

Top Topics

Top Venues

Mary Eileen Dolan (M Eileen Dolan)